107.521 articles found

SUSTAINED RELEASE TABLET FORMULATION TO TREAT PARKINSON DISEASE

JU TZU-CHI ROBERT.

· 1998-09-03

SUSTAINED RELEASE TABLET FORMULATION TO TREAT PARKINSON DISEASE

JU Tzu-chi Robert.

· 1998-09-03

SUSTAINED RELEASE TABLET FORMULATION TO TREAT PARKINSON DISEASE

JU TZU-CHI ROBERT.

· 1998-09-03

Pharmaceutical composition for sustained release containing active ingredient, starch and methyl cellulose for treating parkinson disease

JU TZU-CHI ROBERT.

· 1998-09-03

Neurochemical and neurogenetic correlates of Parkinson's disease.

Mizuno Y, Hattori N, Matsumine H.

J Neurochem · 1998-09-01

DOI: 10.1046/j.1471-4159.1998.71030893.xPMID: 9721714

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

Messa C, Volonté MA, Fazio F, Zito F, Carpinelli A, d'Amico A, Rizzo G, Moresco RM, Paulesu E, Franceschi M, Lucignani G.

Eur J Nucl Med · 1998-09-01

DOI: 10.1007/s002590050295PMID: 9724376

Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation.

Rowe DB, Le W, Smith RG, Appel SH.

J Neurosci Res · 1998-09-01

DOI: 10.1002/(sici)1097-4547(19980901)53:5<551::aid-jnr5>3.0.co;2-8PMID: 9726426

Motor switching abilities in Parkinson's disease and old age: temporal aspects.

Plotnik M, Flash T, Inzelberg R, Schechtman E, Korczyn AD.

J Neurol Neurosurg Psychiatry · 1998-09-01

DOI: 10.1136/jnnp.65.3.328PMID: 9728944

The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom.

Warner TT, Schapira AH.

J Neurol Neurosurg Psychiatry · 1998-09-01

DOI: 10.1136/jnnp.65.3.378PMID: 9728955

A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.

Eberling JL, Jagust WJ, Taylor S, Bringas J, Pivirotto P, VanBrocklin HF, Bankiewicz KS.

Brain Res · 1998-09-01

DOI: 10.1016/s0006-8993(98)00710-0PMID: 9733979

Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease.

Masterman D, DeSalles A, Baloh RW, Frysinger R, Foti D, Behnke E, Cabatan-Awang C, Hoetzel A, Intemann PM, Fairbanks L, Bronstein JM.

Arch Neurol · 1998-09-01

DOI: 10.1001/archneur.55.9.1201PMID: 9740114

Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group.

Sethi KD, O'Brien CF, Hammerstad JP, Adler CH, Davis TL, Taylor RL, Sanchez-Ramos J, Bertoni JM, Hauser RA.

Arch Neurol · 1998-09-01

DOI: 10.1001/archneur.55.9.1211PMID: 9740115